Items where authors include "Harper-Wynne, C."

Export as [feed] Atom [feed] RSS
Number of items: 7.

Article

Coakley, M. orcid.org/0000-0003-2658-7789, Villacampa, G. orcid.org/0000-0003-4868-6585, Sritharan, P. orcid.org/0009-0004-9733-3596 et al. (21 more authors) (2024) Comparison of circulating tumor DNA assays for molecular residual disease detection in early-stage triple-negative breast cancer. Clinical Cancer Research, 30 (4). pp. 895-903. ISSN 1078-0432

Starkey, T., Ionescu, M.C., Tilby, M. et al. (64 more authors) (2023) A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP). Scientific Reports, 13. 11327. ISSN 2045-2322

El Badri, S., Tahir, B., Balachandran, K. et al. (18 more authors) (2021) Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer : a real-world multicentre UK study. The Breast, 60. pp. 199-205. ISSN 0960-9776

Schmid, P., Zaiss, M., Harper-Wynne, C. et al. (29 more authors) (2019) Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor–positive metastatic breast cancer: the MANTA phase 2 randomized clinical trial. JAMA Oncology, 5 (11). pp. 1556-1564. ISSN 2374-2445

Tutt, A., Tovey, H., Cheang, M.C.U. et al. (35 more authors) (2018) Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nature Medicine, 24 (5). pp. 628-637. ISSN 1078-8956

Proceedings Paper

Harper-Wynne, C., Owen, J., Velikova, G. orcid.org/0000-0003-1899-5942 et al. (3 more authors) (2023) A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2+unresectable locally advanced or metastatic breast cancer (aBC): Interim results of the ESTHER study (NCT02393924). In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, IL. American Society of Clinical Oncology , Alexandria, Virginia, USA .

El Badri, S., Tahir, B. orcid.org/0000-0003-0531-3519, Balachandran, K. et al. (16 more authors) (2021) 245P Palbociclib combined with aromatase inhibitors (AIs) in women ≥75 years with oestrogen receptor positive (ER+ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer: a real-world multicentre UK study. In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Virtual conference. Elsevier BV , S466-S466.

This list was generated on Sat Mar 23 20:47:48 2024 GMT.